This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
entity | type | frequency |
---|---|---|
covid | ORG | 376 |
oxygen | CHEMICAL | 175 |
ards | DISEASE | 160 |
peep | ORG | 151 |
covid 19 | ORG | 141 |
infection | DISEASE | 130 |
ketamine | GPE | 125 |
death | DISEASE | 125 |
sargramostim | ORG | 123 |
copd | ORG | 122 |
enoxaparin | CHEMICAL | 111 |
vte | ORG | 109 |
sars | DISEASE | 95 |
ctcae | ORG | 90 |
gm | CHEMICAL | 86 |
viral | TAXON | 80 |
pneumonia | DISEASE | 77 |
azithromycin | CHEMICAL | 77 |
cancer | DISEASE | 72 |
bsc | ORG | 72 |
crf | DISEASE | 69 |
sae | ORG | 68 |
iloprost | CHEMICAL | 67 |
dementia | DISEASE | 67 |
dmc | ORG | 62 |
critically ill | DISEASE | 61 |
bronchiectasis | DISEASE | 59 |
hypertension | DISEASE | 55 |
fio | CHEMICAL | 55 |
sarilumab | CHEMICAL | 53 |
ciprofloxacin | CHEMICAL | 52 |
virus | TAXON | 51 |
inflammation | DISEASE | 51 |
trauma | DISEASE | 50 |
bleeding | DISEASE | 50 |
hydroxychloroquine | CHEMICAL | 49 |
bronchiolitis | DISEASE | 49 |
china | GPE | 48 |
lung injury | DISEASE | 47 |
cpap | ORG | 45 |
heparin | PERSON | 45 |
human | TAXON | 44 |
journal | ORG | 42 |
respiratory distress syndrome | DISEASE | 41 |
sars cov 2 | ORG | 41 |
ketamine | GPE | 41 |
cov | ORG | 41 |
chlamydia | TAXON | 41 |
cancer | DISEASE | 40 |
alxn1210 | CHEMICAL | 40 |
asthma | DISEASE | 39 |
pain | DISEASE | 38 |
leukine | PERSON | 38 |
bacterial | TAXON | 37 |
tcm | ORG | 37 |
cough | DISEASE | 35 |
soc | CHEMICAL | 34 |
balance | ORG | 34 |
ga | ORG | 34 |
exacerbations | DISEASE | 34 |
hypoxaemia | DISEASE | 34 |
fever | DISEASE | 33 |
le | GPE | 32 |
enoxaparin | GPE | 32 |
dengue | DISEASE | 31 |
breast cancer | DISEASE | 31 |
pe | CHEMICAL | 31 |
acute lung injury | DISEASE | 30 |
anakinra | ORG | 30 |
issnhl | ORG | 30 |
infections | DISEASE | 30 |
coronavirus | TAXON | 30 |
individuals | TAXON | 30 |
respiratory failure | DISEASE | 30 |
viruses | TAXON | 29 |
stroke | DISEASE | 29 |
hypoxia | DISEASE | 29 |
prednisone | CHEMICAL | 28 |
streptomycin | CHEMICAL | 28 |
mice | TAXON | 27 |
ich | DISEASE | 27 |
dsmb | ORG | 27 |
gum arabic | PERSON | 27 |
delirium | DISEASE | 27 |
lmwh | ORG | 27 |
aspirin | CHEMICAL | 27 |
un | ORG | 26 |
glucocorticoids | CHEMICAL | 26 |
uk | GPE | 26 |
gcp | ORG | 26 |
bp | ORG | 26 |
bubonic plague | ORG | 25 |
ipm | ORG | 25 |
imp | ORG | 25 |
coronavirus | TAXON | 25 |
aspirin | ORG | 24 |
lifelab | PERSON | 23 |
rct | ORG | 23 |
aegypti | TAXON | 23 |
wuhan | GPE | 23 |
sepsis | DISEASE | 22 |
trials | ORG | 22 |
iloprost | ORG | 22 |
iqr | ORG | 22 |
il | ORG | 22 |
coagulopathy | DISEASE | 21 |
asthma exacerbations | DISEASE | 21 |
investigator | ORG | 20 |
dementia | GPE | 20 |
hfnc | ORG | 20 |
venous thromboembolism | DISEASE | 20 |
bacteria | TAXON | 20 |
deaths | DISEASE | 20 |
azithromycin | GPE | 19 |
igg | ORG | 19 |
mers | DISEASE | 19 |
rm | ORG | 19 |
acute hypoxic respiratory failure | DISEASE | 19 |
mosquito | TAXON | 19 |
statins | CHEMICAL | 19 |
propofol | CHEMICAL | 19 |
des | CHEMICAL | 18 |
bias | CHEMICAL | 18 |
eortc | ORG | 18 |
ecg | ORG | 18 |
anakinra | PERSON | 17 |
eminent | PERSON | 17 |
gm csf | ORG | 17 |
rds | ORG | 17 |
swissmedic | ORG | 17 |
australia | GPE | 17 |
chronic obstructive pulmonary disease | DISEASE | 17 |
failure | DISEASE | 17 |
hypertensive | DISEASE | 17 |
thromboembolic | DISEASE | 17 |
tocilizumab | CHEMICAL | 17 |
toxicity | DISEASE | 17 |
atorvastatin | ORG | 16 |
hot | CHEMICAL | 16 |
ovid | ORG | 16 |
sofa | ORG | 16 |
animal | TAXON | 16 |
bacteremia | DISEASE | 16 |
creatinine | CHEMICAL | 16 |
hypersensitivity | DISEASE | 16 |
septoplasty | GPE | 16 |
thrombocytopenia | DISEASE | 16 |
pd | DISEASE | 15 |
be | CHEMICAL | 15 |
bpd | ORG | 15 |
denv | TAXON | 15 |
iv | ORG | 15 |
mbv | ORG | 15 |
norway | GPE | 15 |
methylprednisolone | CHEMICAL | 15 |
rdt | ORG | 15 |
vas | ORG | 15 |
bivalirudin | PERSON | 15 |
budesonide formoterol | CHEMICAL | 15 |
respiratory illness | DISEASE | 15 |
stroke | PERSON | 15 |
un | ORG | 14 |
cpp | ORG | 14 |
niv | ORG | 14 |
pi | ORG | 14 |
snot | ORG | 14 |
amoxicillin clavulanic acid | ORG | 14 |
enoxaparin sodium | CHEMICAL | 14 |
heart failure | DISEASE | 14 |
protocole | CHEMICAL | 14 |
shock | DISEASE | 14 |
thrombosis | DISEASE | 14 |
miracle | ORG | 13 |
ci | ORG | 13 |
crct | ORG | 13 |
dvt | PERSON | 13 |
ec | ORG | 13 |
hcs | ORG | 13 |
nasal obstruction | DISEASE | 13 |
madagascar | GPE | 13 |
pa | ORG | 13 |
sc | ORG | 13 |
penicillin | GPE | 13 |
rats | TAXON | 13 |
tmg | ORG | 12 |
clinicaltrials | ORG | 12 |
coronavirus disease | DISEASE | 12 |
ecmo | ORG | 12 |
edta | ORG | 12 |
france | GPE | 12 |
imv | CHEMICAL | 12 |
npr | ORG | 12 |
new zealand | GPE | 12 |
sars cov | ORG | 12 |
pain | DISEASE | 12 |
tocilizumab | PERSON | 12 |
macrolide | CHEMICAL | 12 |
bloodstream infection | DISEASE | 12 |
multicentre | ORG | 12 |
malaria | TAXON | 12 |
macrolides | CHEMICAL | 12 |
mosquitoes | TAXON | 12 |
hypoxemia | DISEASE | 12 |
humans | TAXON | 12 |
fentanyl | CHEMICAL | 12 |
vestibular dysfunction | DISEASE | 12 |
jwby | ORG | 11 |
abv illness | DISEASE | 11 |
beijing | GPE | 11 |
guatemala | GPE | 11 |
human | TAXON | 11 |
ics | CHEMICAL | 11 |
irb | ORG | 11 |
igm | ORG | 11 |
itt | ORG | 11 |
los | DISEASE | 11 |
merida | GPE | 11 |
pcr | ORG | 11 |
acute respiratory distress syndrome | DISEASE | 11 |
corticosteroids | CHEMICAL | 11 |
gravité | CHEMICAL | 11 |
infected | DISEASE | 11 |
vertigo | DISEASE | 11 |
masking | CHEMICAL | 11 |
gcs | ORG | 10 |
il 6 | ORG | 10 |
il 1 | ORG | 10 |
iii | ORG | 10 |
ii | ORG | 10 |
hydroxychloroquine | CHEMICAL | 10 |
hmi | ORG | 10 |
berlin | GPE | 10 |
eu | ORG | 10 |
death | DISEASE | 10 |
chikv | ORG | 10 |
appendix | ORG | 10 |
pneumonia | DISEASE | 10 |
abv infection | DISEASE | 10 |
mrc | ORG | 10 |
respiratory distress | DISEASE | 10 |
ris | ORG | 10 |
zikv | ORG | 10 |
steroids | CHEMICAL | 10 |
fibrosis | DISEASE | 10 |
bloodstream | TAXON | 10 |
bilirubin | CHEMICAL | 10 |
anaphylaxis | DISEASE | 10 |
fibrosis bronchiectasis | DISEASE | 10 |
us | GPE | 10 |
ssnhl | ORG | 10 |
tnf | ORG | 10 |
sap | ORG | 10 |
respiratory distress syndrome | DISEASE | 10 |
soa | ORG | 10 |
tirs | ORG | 10 |
sot | ORG | 9 |
cec | ORG | 9 |
ciprofloxacin | ORG | 9 |
fda | ORG | 9 |
germany | GPE | 9 |
icf | ORG | 9 |
kaplan meier | PERSON | 9 |
la | GPE | 9 |
nhs | ORG | 9 |
nasal | PERSON | 9 |
edc | CHEMICAL | 9 |
pour | GPE | 9 |
sodium chloride | CHEMICAL | 9 |
muscle wasting | DISEASE | 9 |
tritube | GPE | 9 |
sodium chloride | CHEMICAL | 9 |
pourra | CHEMICAL | 9 |
obesity | DISEASE | 9 |
respiratory syndrome | DISEASE | 9 |
mouse | TAXON | 9 |
major bleeding | DISEASE | 9 |
cardiovascular disease | DISEASE | 9 |
cachexia | DISEASE | 9 |
atorvastatin | ORG | 9 |
italy | GPE | 8 |
sas | ORG | 8 |
nacl 0 9 | CHEMICAL | 8 |
net | ORG | 8 |
nairos | ORG | 8 |
methylprednisolone | ORG | 8 |
leukine | ORG | 8 |
k | ORG | 8 |
cure | ORG | 8 |
incidence | ORG | 8 |
hypertension | DISEASE | 8 |
fas | ORG | 8 |
discussion | ORG | 8 |
chloroquine | ORG | 8 |
aerogen | ORG | 8 |
switzerland | GPE | 8 |
sylvant | ORG | 8 |
nps | ORG | 8 |
toc | ORG | 8 |
dexmedetomidine | CHEMICAL | 8 |
tsc | ORG | 8 |
sensorineural hearing loss | DISEASE | 8 |
sargramostim 125mcg m 2 body surface area | CHEMICAL | 8 |
respiratory disease | DISEASE | 8 |
overdose | DISEASE | 8 |
morphine | CHEMICAL | 8 |
malnutrition | DISEASE | 8 |
respiratory exacerbations | DISEASE | 8 |
desaturation | DISEASE | 8 |
allergy | DISEASE | 8 |
acute stroke | DISEASE | 8 |
wilcoxon | ORG | 8 |
viral infections | DISEASE | 8 |
vap | ORG | 8 |
time | ORG | 8 |
congenital anomaly | DISEASE | 8 |
oxygen | CHEMICAL | 7 |
live | ORG | 7 |
laboratory | ORG | 7 |
middle east | LOC | 7 |
ministry of health | ORG | 7 |
nih | ORG | 7 |
qri | ORG | 7 |
pnif | ORG | 7 |
pump | ORG | 7 |
pao 2 fio 2 | ORG | 7 |
sli | ORG | 7 |
kce | ORG | 7 |
ldh | ORG | 7 |
blood | ORG | 7 |
inclusion | ORG | 7 |
gram | PERSON | 7 |
gp | ORG | 7 |
europe | LOC | 7 |
ethics committee | ORG | 7 |
enoxaparin sodium | CHEMICAL | 7 |
delirium | GPE | 7 |
critère | ORG | 7 |
ulrik | DISEASE | 7 |
argentina | GPE | 7 |
aedes aegypti | TAXON | 7 |
aedes | TAXON | 7 |
acc | ORG | 7 |
subject | ORG | 7 |
ne | CHEMICAL | 7 |
vestibular | ORG | 7 |
glucose | CHEMICAL | 7 |
x ray | PERSON | 7 |
tachycardia | DISEASE | 7 |
sodium | CHEMICAL | 7 |
renal failure | DISEASE | 7 |
nitric oxide | CHEMICAL | 7 |
neutrophil | GPE | 7 |
multi organ failure | DISEASE | 7 |
metoclopramide | CHEMICAL | 7 |
lopinavir ritonavir | CHEMICAL | 7 |
ischemia | DISEASE | 7 |
interstitial pneumonia | DISEASE | 7 |
inferiority | DISEASE | 7 |
hyperinflammatory syndrome | DISEASE | 7 |
midazolam | CHEMICAL | 7 |
dyspnea | DISEASE | 7 |
bloodstream infections | DISEASE | 7 |
yucatan | GPE | 7 |
dysbiosis | DISEASE | 7 |
acute respiratory distress syndrome ards | DISEASE | 7 |
acute respiratory failure | DISEASE | 7 |
atrial fibrillation | DISEASE | 7 |
allergic reactions | DISEASE | 7 |
bronchiectasis exacerbations | DISEASE | 7 |
comorbidity | DISEASE | 7 |
coronavirus disease | DISEASE | 7 |
diabetes | DISEASE | 7 |
netherlands | GPE | 6 |
nose | ORG | 6 |
ra | ORG | 6 |
o2 | CHEMICAL | 6 |
pk pd | ORG | 6 |
pps | ORG | 6 |
precious | ORG | 6 |
prism | DISEASE | 6 |
srm | ORG | 6 |
rac | ORG | 6 |
rass | ORG | 6 |
rms | CHEMICAL | 6 |
saa | ORG | 6 |
sepsis | DISEASE | 6 |
statins | ORG | 6 |
mh | ORG | 6 |
mexico | GPE | 6 |
bronchiectasis | ORG | 6 |
isth | GPE | 6 |
coronavirus disease | DISEASE | 6 |
traumadornase | ORG | 6 |
alexion gds | ORG | 6 |
bivalirudin | PERSON | 6 |
bronchiolitis | GPE | 6 |
c5b 9 | CHEMICAL | 6 |
cop | CHEMICAL | 6 |
dhi | ORG | 6 |
irs | ORG | 6 |
dp | GPE | 6 |
darwin | PERSON | 6 |
eig | ORG | 6 |
famhp | ORG | 6 |
groetzinger | GPE | 6 |
gut microbiota | PERSON | 6 |
streptomycin | LOC | 6 |
hyperinflammation | DISEASE | 6 |
acute respiratory syndrome | DISEASE | 6 |
lung damage | DISEASE | 6 |
multiorgan failure | DISEASE | 6 |
organ failure | DISEASE | 6 |
psychiatric | DISEASE | 6 |
pulmonary hypertension | DISEASE | 6 |
rat | TAXON | 6 |
respiratory infection | DISEASE | 6 |
sprays | CHEMICAL | 6 |
steroid | CHEMICAL | 6 |
the ministry of health | ORG | 6 |
tinnitus | DISEASE | 6 |
tocilizumab tocilizumab | PERSON | 6 |
traumatic | DISEASE | 6 |
viral disease | DISEASE | 6 |
alanine | CHEMICAL | 6 |
viral infection | DISEASE | 6 |
mmhg | ORG | 6 |
statin | CHEMICAL | 6 |
liver disease | DISEASE | 6 |
dizziness | DISEASE | 6 |
ampicillin | CHEMICAL | 6 |
app | ORG | 6 |
intravascular coagulation | DISEASE | 6 |
aspartate | CHEMICAL | 6 |
bubo | TAXON | 6 |
contrôle | DISEASE | 6 |
des personnes | CHEMICAL | 6 |
cholesterol | CHEMICAL | 6 |
ferritin lymphopenia | PERSON | 6 |
fondaparinux | CHEMICAL | 6 |
gentamicin | CHEMICAL | 6 |
house | TAXON | 6 |
hypercapnia | GPE | 6 |
irb iec | ORG | 5 |
mann whitney u | PERSON | 5 |
irm | ORG | 5 |
identifier | ORG | 5 |
jh | PERSON | 5 |
jens ulrik | PERSON | 5 |
km | PERSON | 5 |
id | DISEASE | 5 |
map | ORG | 5 |
mers cov infection | ORG | 5 |
peking university first hospital | ORG | 5 |
monitoring | LOC | 5 |
pis | ORG | 5 |
ps | PERSON | 5 |
pwd | ORG | 5 |
plasma | PERSON | 5 |
reference | PERSON | 5 |
rivaroxaban | CHEMICAL | 5 |
hrt | ORG | 5 |
saba | PERSON | 5 |
ich gcp | ORG | 5 |
alexion | LOC | 5 |
ghent university hospital | ORG | 5 |
fcv | ORG | 5 |
sensitivity | ORG | 5 |
abv infections | DISEASE | 5 |
ad | DISEASE | 5 |
ancova | ORG | 5 |
attainment | PERSON | 5 |
agitation | DISEASE | 5 |
bal | ORG | 5 |
belgium | GPE | 5 |
breast cancer | DISEASE | 5 |
brescia covid 2 3 | ORG | 5 |
cdc | ORG | 5 |
copd exacerbations | DISEASE | 5 |
coagulopathy | DISEASE | 5 |
control | ORG | 5 |
cox | ORG | 5 |
d11 | PERSON | 5 |
d21 | PERSON | 5 |
dnase | ORG | 5 |
dengue | TAXON | 5 |
stata | ORG | 5 |
pruritus | DISEASE | 5 |
shanghai | GPE | 5 |
idiopathic sudden sensorineural hearing loss | DISEASE | 5 |
injuries | DISEASE | 5 |
lactate | CHEMICAL | 5 |
lung inflammation | DISEASE | 5 |
multiorgan | GPE | 5 |
myocardial infarction | DISEASE | 5 |
ncov | ORG | 5 |
otitis | DISEASE | 5 |
paracetamol | PERSON | 5 |
plague | GPE | 5 |
pneumothorax | DISEASE | 5 |
pravastatin | PERSON | 5 |
protamine | PERSON | 5 |
pulmonary hemorrhage | DISEASE | 5 |
renal insufficiency | DISEASE | 5 |
the ethics committee | ORG | 5 |
the united states | GPE | 5 |
téléphonique | DISEASE | 5 |
viral pneumonia | DISEASE | 5 |
spain | GPE | 5 |
infectious diseases | DISEASE | 5 |
shortness of breath | DISEASE | 5 |
hypotension | DISEASE | 5 |
budesonide | CHEMICAL | 5 |
thilo | PERSON | 5 |
humaine | CHEMICAL | 5 |
thrombocytopenia | GPE | 5 |
who | ORG | 5 |
yersinia | TAXON | 5 |
zika | PERSON | 5 |
alcohol | CHEMICAL | 5 |
analgesia | GPE | 5 |
bacterial infections | DISEASE | 5 |
uw | ORG | 5 |
chronic lung disease | DISEASE | 5 |
glycerol | CHEMICAL | 5 |
de gravité | PERSON | 5 |
depression | DISEASE | 5 |
des données | CHEMICAL | 5 |
diarrhea | DISEASE | 5 |
dysphagia | ORG | 5 |
haemophagocytic lymphohistiocytosis | DISEASE | 5 |
creatinine urea | CHEMICAL | 5 |
nctu | ORG | 4 |
nct02917551 | CHEMICAL | 4 |
n meningitidis | ORG | 4 |
mycoplasma | ORG | 4 |
mometasone | TAXON | 4 |
mann whitney | PERSON | 4 |
mbs | ORG | 4 |
josefin | ORG | 4 |
les | ORG | 4 |
kevzara | GPE | 4 |
jia wei | PERSON | 4 |
ivrs | GPE | 4 |
itti | ORG | 4 |
insure | ORG | 4 |
nomid | ORG | 4 |
ima | ORG | 4 |
nihss | DISEASE | 4 |
pao2 fio2 | ORG | 4 |
nyha iii iv | GPE | 4 |
period | CHEMICAL | 4 |
hôpital | CHEMICAL | 4 |
rna | ORG | 4 |
rdw | ORG | 4 |
qatar | GPE | 4 |
procalcitonin | CHEMICAL | 4 |
pi | PERSON | 4 |
partner therapeutics inc | ORG | 4 |
na k | LOC | 4 |
pao | ORG | 4 |
pta | ORG | 4 |
ppe | CHEMICAL | 4 |
osa | ORG | 4 |
o2 gradient | CHEMICAL | 4 |
neutrophil | GPE | 4 |
ifn | ORG | 4 |
cart | ORG | 4 |
healthcare | ORG | 4 |
allergy | DISEASE | 4 |
covid acalabrutinib | ORG | 4 |
c5ar | CHEMICAL | 4 |
bsh | ORG | 4 |
australian indigenous | LOC | 4 |
anticoagulation | CHEMICAL | 4 |
annexe | PERSON | 4 |
access | ORG | 4 |
clinicalstudies | ORG | 4 |
auc | ORG | 4 |
alri | GPE | 4 |
ali | ORG | 4 |
aemps | ORG | 4 |
6rα | PERSON | 4 |
se | DISEASE | 4 |
cenduit | ORG | 4 |
coma | DISEASE | 4 |
hampshire | GPE | 4 |
ethics | ORG | 4 |
hrqol | PERSON | 4 |
hra | CHEMICAL | 4 |
hdac | PERSON | 4 |
grv | ORG | 4 |
experimental | LOC | 4 |
evone | CHEMICAL | 4 |
enoxaparin inhixa | PERSON | 4 |
doass | ORG | 4 |
enoxaparin clexane | PERSON | 4 |
england | GPE | 4 |
emory university | ORG | 4 |
dyssynchrony | PERSON | 4 |
dexmedetomidine | PERSON | 4 |
denmark | GPE | 4 |
rt pcr | ORG | 4 |
acute | ORG | 4 |
sobi | ORG | 4 |
doxycycline | CHEMICAL | 4 |
malignancy | DISEASE | 4 |
lambs | TAXON | 4 |
ischaemic stroke | DISEASE | 4 |
influenza infection | DISEASE | 4 |
hypoxic respiratory failure | DISEASE | 4 |
hyposmia | DISEASE | 4 |
hypersalivation | DISEASE | 4 |
host | TAXON | 4 |
hepatitis c | DISEASE | 4 |
hematoma | DISEASE | 4 |
gut microbiota | PERSON | 4 |
flavivirus | TAXON | 4 |
ferritin | GPE | 4 |
exacerbations of chronic obstructive pulmonary disease | DISEASE | 4 |
estrogen | CHEMICAL | 4 |
muscle atrophy | DISEASE | 4 |
nitrogen | CHEMICAL | 4 |
organisms | TAXON | 4 |
spss | ORG | 4 |
vivo | GPE | 4 |
vitro | GPE | 4 |
the northern territory | LOC | 4 |
the european union | ORG | 4 |
syncytial virus | TAXON | 4 |
septic shock | DISEASE | 4 |
sargramostim leukine | CHEMICAL | 4 |
peripheral sensory neuropathy rash | DISEASE | 4 |
rheumatoid arthritis | DISEASE | 4 |
respiratory tract infection | DISEASE | 4 |
respiratory symptoms | DISEASE | 4 |
respiratory infections | DISEASE | 4 |
respiratory dysfunction | DISEASE | 4 |
prostacyclin | CHEMICAL | 4 |
drug s concomitant disease | DISEASE | 4 |
turbinate reduction | DISEASE | 4 |
disability incapacity | DISEASE | 4 |
streptococcus | GPE | 4 |
agitation | DISEASE | 4 |
acute ischemic stroke | DISEASE | 4 |
acute illness | DISEASE | 4 |
vfd | DISEASE | 4 |
uc | DISEASE | 4 |
toxicity | DISEASE | 4 |
springer nature | PERSON | 4 |
amino acid | CHEMICAL | 4 |
southampton | ORG | 4 |
simvastatin | PERSON | 4 |
sequential organ failure assessment sofa | ORG | 4 |
septoplasty | PERSON | 4 |
ssy | ORG | 4 |
dengue virus | TAXON | 4 |
amenorrhea | PERSON | 4 |
santé | DISEASE | 4 |
amoxicillin clavulanic | ORG | 4 |
chronic kidney disease | DISEASE | 4 |
anakinra siltuximab | PERSON | 4 |
de l | ORG | 4 |
coronary syndrome | DISEASE | 4 |
coma | DISEASE | 4 |
chronic suppurative lung disease | DISEASE | 4 |
chronic obstructive pulmonary disease copd | DISEASE | 4 |
de nez | PERSON | 4 |
chloroquine | CHEMICAL | 4 |
cardiovascular liver and kidney failure | DISEASE | 4 |
bubonic | DISEASE | 4 |
benzodiazepine | CHEMICAL | 4 |
barotrauma | DISEASE | 4 |
ceftriaxone | CHEMICAL | 4 |
anakinra siltuximab siltuximab | CHEMICAL | 4 |
lopinavir ritonavir | CHEMICAL | 3 |
lancet | ORG | 3 |
latin america | LOC | 3 |
le promoteur | CHEMICAL | 3 |
login | PERSON | 3 |
london | GPE | 3 |
medi3506 | CHEMICAL | 3 |
ma | ORG | 3 |
mariner | ORG | 3 |
mmrm | ORG | 3 |
mobid | ORG | 3 |
mof | ORG | 3 |
lack | PERSON | 3 |
ms | ORG | 3 |
moh | ORG | 3 |
juj | ORG | 3 |
lmst | ORG | 3 |
interna | GPE | 3 |
ics laba | ORG | 3 |
mantel haenszel | PERSON | 3 |
intervention | ORG | 3 |
immunoglobulins m and g igm | ORG | 3 |
infection | DISEASE | 3 |
interim | ORG | 3 |
j30 | CHEMICAL | 3 |
laba | CHEMICAL | 3 |
jb | ORG | 3 |
jhajjar haryana | PERSON | 3 |
jun | PERSON | 3 |
kg | PERSON | 3 |
kineret | PERSON | 3 |
kjr | ORG | 3 |
malnutrition | DISEASE | 3 |
prevalence | PERSON | 3 |
mashhad university of medical sciences | ORG | 3 |
randomisation | ORG | 3 |
pulmonary embolism | ORG | 3 |
qy | ORG | 3 |
questionnaire | ORG | 3 |
rec | GPE | 3 |
reduce | ORG | 3 |
rud | ORG | 3 |
ravulizumab | ORG | 3 |
medical | ORG | 3 |
reglamento | GPE | 3 |
reliability | ORG | 3 |
sars infection | DISEASE | 3 |
sf | GPE | 3 |
ssg | ORG | 3 |
iac | CHEMICAL | 3 |
psychometric | PERSON | 3 |
pseudomonas | GPE | 3 |
prone | ORG | 3 |
pre | ORG | 3 |
pradeesh sivapalan | PERSON | 3 |
parents | ORG | 3 |
paracetamol | CHEMICAL | 3 |
pf | ORG | 3 |
pbs | ORG | 3 |
padis | ORG | 3 |
orl | ORG | 3 |
numbers | ORG | 3 |
next | ORG | 3 |
new delhi | GPE | 3 |
ngt | ORG | 3 |
multicentre | PERSON | 3 |
merida mexico | GPE | 3 |
ib | ORG | 3 |
cure rct | ORG | 3 |
hypoxaemia | ORG | 3 |
brien fleming | PERSON | 3 |
au | CHEMICAL | 3 |
aucune | LOC | 3 |
bacteremia | DISEASE | 3 |
bergen | ORG | 3 |
bergen baerum | PERSON | 3 |
brescia covid 2 | ORG | 3 |
bushen yiqi | PERSON | 3 |
smpc | ORG | 3 |
butyrate | PERSON | 3 |
ca | GPE | 3 |
cam | ORG | 3 |
cfu | ORG | 3 |
covid 19 change | ORG | 3 |
covid infection | DISEASE | 3 |
arabia | TAXON | 3 |
analysis | LOC | 3 |
alzheimer s disease | DISEASE | 3 |
allocation | ORG | 3 |
adverse events ctcae | ORG | 3 |
acacia senegal gum arabic | PERSON | 3 |
acacia senegal | PERSON | 3 |
ast | ORG | 3 |
asa | ORG | 3 |
ar | ORG | 3 |
aqi | ORG | 3 |
ance | CHEMICAL | 3 |
amm | ORG | 3 |
ami | CHEMICAL | 3 |
ag | CHEMICAL | 3 |
acp | ORG | 3 |
abc | ORG | 3 |
ctu | ORG | 3 |
cure soft | PERSON | 3 |
huang qin | PERSON | 3 |
gina | ORG | 3 |
discharge | PERSON | 3 |
duration | PERSON | 3 |
eq | PERSON | 3 |
escherichia | PERSON | 3 |
flyer | ORG | 3 |
gi | ORG | 3 |
general data protection regulation gdpr | ORG | 3 |
cvd | ORG | 3 |
good clinical practice gcp | ORG | 3 |
group d | PERSON | 3 |
h1n1 | GPE | 3 |
hem | DISEASE | 3 |
hlh | ORG | 3 |
hot line | PERSON | 3 |
depression | DISEASE | 3 |
data monitoring committee | ORG | 3 |
data | ORG | 3 |
dress | ORG | 3 |
damp | ORG | 3 |
d11 proportion of | ORG | 3 |
creatinine | CHEMICAL | 3 |
cpap | GPE | 3 |
community | ORG | 3 |
collect | ORG | 3 |
cognitive impairment | DISEASE | 3 |
cochran mantel haenszel | PERSON | 3 |
cluster | PERSON | 3 |
clexane | CHEMICAL | 3 |
chronic obstructive pulmonary disease | ORG | 3 |
central america | LOC | 3 |
cancer australia | ORG | 3 |
scientific committee | ORG | 3 |
japan | GPE | 3 |
standard | LOC | 3 |
perforation | DISEASE | 3 |
neuromuscular blockade | DISEASE | 3 |
neuropsychiatric symptoms | DISEASE | 3 |
neutropenia | DISEASE | 3 |
nosocomial infection | DISEASE | 3 |
nucleic acid | CHEMICAL | 3 |
opacities | DISEASE | 3 |
persistante | CHEMICAL | 3 |
myocardial ischaemia | DISEASE | 3 |
plaque | DISEASE | 3 |
pneumonia vap | DISEASE | 3 |
pneumonias | DISEASE | 3 |
preterm | PERSON | 3 |
preterm neonates | GPE | 3 |
prior heparin | PERSON | 3 |
myocarditis | DISEASE | 3 |
mometasone furoate | CHEMICAL | 3 |
hepatic impairment | DISEASE | 3 |
leukemia | DISEASE | 3 |
influenza | ORG | 3 |
interferon | ORG | 3 |
interstitial lung disease | DISEASE | 3 |
intracranial hemorrhage | DISEASE | 3 |
investigateur | CHEMICAL | 3 |
ischemic stroke | DISEASE | 3 |
lipoxin | CHEMICAL | 3 |
mometasone | CHEMICAL | 3 |
lithium carbonate | CHEMICAL | 3 |
lung disease | DISEASE | 3 |
lymphopenia cardiac symptoms | DISEASE | 3 |
man | TAXON | 3 |
mesenteric and extremities acute splanchnic vein thrombosis | DISEASE | 3 |
metoclopramide ceftriaxone paracetamol | CHEMICAL | 3 |
pulmonary and vessel inflammation | DISEASE | 3 |
que | ORG | 3 |
respiratory diseases | DISEASE | 3 |
urea nitrogen | CHEMICAL | 3 |
the sponsor investigator | ORG | 3 |
the university of bergen | ORG | 3 |
the university of oxford | ORG | 3 |
thrombotic | DISEASE | 3 |
thrombotic complications | DISEASE | 3 |
toxicities | DISEASE | 3 |
venous thromboembolic disease | DISEASE | 3 |
respiratory injury | DISEASE | 3 |
venous thromboembolism vte | DISEASE | 3 |
viral respiratory infection | DISEASE | 3 |
vomiting | DISEASE | 3 |
weight loss | DISEASE | 3 |
être | GPE | 3 |
state | ORG | 3 |
the research council | ORG | 3 |
the relative stress scale | ORG | 3 |
the patient safety information card | ORG | 3 |
the national cancer institute | ORG | 3 |
the data protection regulation | ORG | 3 |
the danish medicines agency | ORG | 3 |
the danish data protection agency | ORG | 3 |
the cockcroft gault | ORG | 3 |
the central ethics committee | ORG | 3 |
supra infections | DISEASE | 3 |
streptomycin ciprofloxacin | CHEMICAL | 3 |
spermicide | CHEMICAL | 3 |
smoking | CHEMICAL | 3 |
simvastatin | PERSON | 3 |
siltuximab | CHEMICAL | 3 |
réponse | CHEMICAL | 3 |
rheumatic diseases | DISEASE | 3 |
immunoparalysis | DISEASE | 3 |
supplémentaires | CHEMICAL | 3 |
heparins | CHEMICAL | 3 |
acalabrutinib zilucoplan | PERSON | 3 |
ventilator | PERSON | 3 |
versuche | ORG | 3 |
viral | TAXON | 3 |
wbc | ORG | 3 |
wolbachia | TAXON | 3 |
yh | ORG | 3 |
active myeloid malignancy | DISEASE | 3 |
vili | PERSON | 3 |
acute injury | DISEASE | 3 |
adrenaline | CHEMICAL | 3 |
adverse reaction | DISEASE | 3 |
airway inflammation | DISEASE | 3 |
airway obstruction | DISEASE | 3 |
allergic | DISEASE | 3 |
vanderbilt university | ORG | 3 |
ves | CHEMICAL | 3 |
aminoglycosides | CHEMICAL | 3 |
the investigator | ORG | 3 |
study data | ORG | 3 |
hearing loss | DISEASE | 3 |
sweden | GPE | 3 |
trial registration australia | ORG | 3 |
technical | ORG | 3 |
the hot line | ORG | 3 |
thromboembolic | ORG | 3 |
vemp | ORG | 3 |
thrombosis | DISEASE | 3 |
toll | PERSON | 3 |
townsville queensland | LOC | 3 |
uady | ORG | 3 |
ufh | ORG | 3 |
vek | ORG | 3 |
allergies | DISEASE | 3 |
usa | GPE | 3 |
antihistamines | CHEMICAL | 3 |
début des signes | CHEMICAL | 3 |
critère | DISEASE | 3 |
cyclosporine | CHEMICAL | 3 |
dans le | PERSON | 3 |
de nez sera | ORG | 3 |
deltamethrin | CHEMICAL | 3 |
dengue chikungunya | DISEASE | 3 |
eculizumab | CHEMICAL | 3 |
cough sore | DISEASE | 3 |
fever cough | DISEASE | 3 |
fracture | DISEASE | 3 |
fungal | TAXON | 3 |
atelectasis | DISEASE | 3 |
gastrointestinal symptoms | DISEASE | 3 |
haemorrhage | DISEASE | 3 |
creatine | CHEMICAL | 3 |
du protocole | ORG | 3 |
cord injury stroke | DISEASE | 3 |
carbon dioxide | CHEMICAL | 3 |
benzodiazepines | CHEMICAL | 3 |
bemcentinib medi3506 | ORG | 3 |
compartment syndrome | DISEASE | 3 |
bleeding diathesis | DISEASE | 3 |
bronchopulmonary dysplasia | DISEASE | 3 |
butyrate | CHEMICAL | 3 |
caffeine | CHEMICAL | 3 |
avian | TAXON | 3 |
cette | CHEMICAL | 3 |
chronic cough | DISEASE | 3 |
clarithromycin | CHEMICAL | 3 |
colchicine | CHEMICAL | 3 |
myocardial infarction | DISEASE | 2 |
muscle wasting | DISEASE | 2 |
medicamentos | CHEMICAL | 2 |
moraxella | CHEMICAL | 2 |
molecular | GPE | 2 |
model | ORG | 2 |
myocardial injury | ORG | 2 |
microsoft | ORG | 2 |
medicare | ORG | 2 |
major bleeding | DISEASE | 2 |
medical research council | ORG | 2 |
mean arterial pressure | ORG | 2 |
mantel | ORG | 2 |
mansilla kristyne | PERSON | 2 |
mrz | ORG | 2 |
mri iac | ORG | 2 |
mic | ORG | 2 |
mar sensitivity | ORG | 2 |
n | ORG | 2 |
medenox | PERSON | 2 |
mdc | ORG | 2 |
münster | DISEASE | 2 |
nihr | ORG | 2 |
nci | ORG | 2 |
nhmrc | ORG | 2 |
naseptin bactroban | PERSON | 2 |
macro | ORG | 2 |
naseptin nasal cream | PERSON | 2 |
nasal cpap | PERSON | 2 |
nacl | CHEMICAL | 2 |
numbers | CHEMICAL | 2 |
no | CHEMICAL | 2 |
nnt | DISEASE | 2 |
nippv | CHEMICAL | 2 |
netosis | ORG | 2 |
nct03005145 | ORG | 2 |
ndc | ORG | 2 |
nct04343521 | CHEMICAL | 2 |
nct0433340 | PERSON | 2 |
nct04322396 | CHEMICAL | 2 |
nct04075006 | CHEMICAL | 2 |
nct03974867 registered | PERSON | 2 |
nct03974867 | CHEMICAL | 2 |
nct03504124 | CHEMICAL | 2 |
nct03368092 | CHEMICAL | 2 |
magellan | ORG | 2 |
intervention | ORG | 2 |
lung injury | DISEASE | 2 |
infectious disease | DISEASE | 2 |
j70 le | PERSON | 2 |
italy bronchiectasis | PERSON | 2 |
iranian registry of clinical trials irct | ORG | 2 |
iran | GPE | 2 |
intracerebral bleeding | DISEASE | 2 |
interventions | GPE | 2 |
interactive response technology irt randomisation | ORG | 2 |
informed consent form | ORG | 2 |
influenza | ORG | 2 |
individuals | TAXON | 2 |
john hunter hospital | ORG | 2 |
il | ORG | 2 |
ige collect | ORG | 2 |
iga igg igm | ORG | 2 |
iga | ORG | 2 |
itn | ORG | 2 |
isf | ORG | 2 |
irr | ORG | 2 |
native | GPE | 2 |
ipd | ORG | 2 |
jmg | ORG | 2 |
ka | CHEMICAL | 2 |
luminex | PERSON | 2 |
lsg | ORG | 2 |
lowest | ORG | 2 |
lingwen | CHEMICAL | 2 |
linear | ORG | 2 |
lifecourse | CHEMICAL | 2 |
li | CHEMICAL | 2 |
leukine leukine | ORG | 2 |
lesley versteegh clare | PERSON | 2 |
le pharmacien | CHEMICAL | 2 |
lambrecht bart | PERSON | 2 |
lib | ORG | 2 |
kfsh rc | ORG | 2 |
lb | GPE | 2 |
l 1123 | CHEMICAL | 2 |
kristiansand | GPE | 2 |
klebsiella | PERSON | 2 |
khadem | CHEMICAL | 2 |
kemimof | PERSON | 2 |
kaplan | ORG | 2 |
kwt | ORG | 2 |
kfsh rc with research advisory council | ORG | 2 |
national cancer institute | ORG | 2 |
sb | CHEMICAL | 2 |
neisseria | GPE | 2 |
residence | ORG | 2 |
sd | DISEASE | 2 |
sarpac | CHEMICAL | 2 |
sar | ORG | 2 |
sail | ORG | 2 |
sabds | CHEMICAL | 2 |
rosuvastatin | PERSON | 2 |
roactemra | LOC | 2 |
results | PERSON | 2 |
respiratory disease | DISEASE | 2 |
research of mashhad university of medical sciences | ORG | 2 |
sic | ORG | 2 |
research ethics committee | ORG | 2 |
research ethics | ORG | 2 |
refer | PERSON | 2 |
reach efficacy adoption implementation maintenance re aim practical robust implementation | ORG | 2 |
rankin | ORG | 2 |
radix | PERSON | 2 |
rs | DISEASE | 2 |
rp | ORG | 2 |
redcap | ORG | 2 |
sds | ORG | 2 |
sjhc | CHEMICAL | 2 |
re aim | ORG | 2 |
si je | PERSON | 2 |
inr | ORG | 2 |
stegomyia | GPE | 2 |
statistical | ORG | 2 |
stage 2 | ORG | 2 |
spray | CHEMICAL | 2 |
spn | ORG | 2 |
simkania negevensis | CHEMICAL | 2 |
simkania | PERSON | 2 |
siltuximab | CHEMICAL | 2 |
shuming | CHEMICAL | 2 |
slw | ORG | 2 |
screen | ORG | 2 |
scotland england | LOC | 2 |
saudi arabia | GPE | 2 |
sargramostim | PERSON | 2 |
su sar | ORG | 2 |
stevens johnson | PERSON | 2 |
spv | ORG | 2 |
snot 22 | ORG | 2 |
smart | ORG | 2 |
redcap vanderbilt university | ORG | 2 |
rdh | ORG | 2 |
new zealand clinical trial registry | ORG | 2 |
pbd | ORG | 2 |
pro | CHEMICAL | 2 |
pmd | ORG | 2 |
pjt | ORG | 2 |
pis | ORG | 2 |
php | ORG | 2 |
pg 0216 20004 | CHEMICAL | 2 |
pes | ORG | 2 |
pdw | ORG | 2 |
pbo | ORG | 2 |
p f ratio | ORG | 2 |
paco2 hco3 | ORG | 2 |
p f | LOC | 2 |
outcomes | ORG | 2 |
omron hem | PERSON | 2 |
objectif dans | PERSON | 2 |
obesity | DISEASE | 2 |
nurse | ORG | 2 |
notwithstanding | ORG | 2 |
norepinephrine 0 2 | PERSON | 2 |
norepinephrine | CHEMICAL | 2 |
pvs | ORG | 2 |
panama | GPE | 2 |
randomisation patients | ORG | 2 |
pocok | ORG | 2 |
quellung | PERSON | 2 |
qol | PERSON | 2 |
qy zw | PERSON | 2 |
qol | GPE | 2 |
qalys | ORG | 2 |
proportion of | ORG | 2 |
preprint | ORG | 2 |
prednisone | CHEMICAL | 2 |
poland | GPE | 2 |
plague | GPE | 2 |
paraquat | ORG | 2 |
pintado | GPE | 2 |
pierre | DISEASE | 2 |
piacenza medicina | PERSON | 2 |
peter s | PERSON | 2 |
periodic | ORG | 2 |
patient | PERSON | 2 |
partner therapeutics | PERSON | 2 |
participating | PERSON | 2 |
paris | GPE | 2 |
ip | ORG | 2 |
adr | ORG | 2 |
imp patient | ORG | 2 |
cc | CHEMICAL | 2 |
covid 19 sf | ORG | 2 |
covid 19 illness | ORG | 2 |
comparator | ORG | 2 |
cm | DISEASE | 2 |
clsi | ORG | 2 |
ckd epi creatinine | ORG | 2 |
cfu bifidobacterium | ORG | 2 |
cd4 | GPE | 2 |
ccctg | ORG | 2 |
cat | ORG | 2 |
covid19 | ORG | 2 |
brescia covid scale | ORG | 2 |
booster nurse clinic | ORG | 2 |
bonferroni | PERSON | 2 |
bloods | ORG | 2 |
binary | GPE | 2 |
bifidobacterium | CHEMICAL | 2 |
bemcentinib | PERSON | 2 |
belgium ethics committee | ORG | 2 |
baseline | ORG | 2 |
covid disease | DISEASE | 2 |
cpap failure | DISEASE | 2 |
barcelona | PERSON | 2 |
cette | CHEMICAL | 2 |
clinical research committee | ORG | 2 |
cleanweb telemedicine technologies s a s | ORG | 2 |
chronic | ORG | 2 |
christchurch hospital | ORG | 2 |
chiew | ORG | 2 |
chicago il usa | ORG | 2 |
chi shao | PERSON | 2 |
chest bronchiectasis | ORG | 2 |
charité | CHEMICAL | 2 |
celgene kl | ORG | 2 |
cpl | ORG | 2 |
castelman s disease | DISEASE | 2 |
cus | ORG | 2 |
ctcae toxicities | CHEMICAL | 2 |
ctc | ORG | 2 |
csc | CHEMICAL | 2 |
csb | ORG | 2 |
crp | ORG | 2 |
cro | ORG | 2 |
crc | ORG | 2 |
barthel index | PERSON | 2 |
bacteraemia | PERSON | 2 |
clínic | DISEASE | 2 |
ac | ORG | 2 |
arf | ORG | 2 |
anova | ORG | 2 |
anc | ORG | 2 |
amv | ORG | 2 |
adi | ORG | 2 |
ada | ORG | 2 |
actrn12619001594112 | CHEMICAL | 2 |
actrn12610000326099 | CHEMICAL | 2 |
acc aha aapa | ORG | 2 |
abv disease | DISEASE | 2 |
aerogen ireland | GPE | 2 |
abv | ORG | 2 |
abg | ORG | 2 |
ab | ORG | 2 |
93ggxzxu | CHEMICAL | 2 |
8dar2p3j | TAXON | 2 |
4035 | DISEASE | 2 |
30 jours afin | CHEMICAL | 2 |
100mmhg | CHEMICAL | 2 |
stool routine | PERSON | 2 |
ash | ORG | 2 |
affilié | CHEMICAL | 2 |
bnp | ORG | 2 |
animal | TAXON | 2 |
bga | ORG | 2 |
australian institute of health and welfare cancer | ORG | 2 |
australia indigenous | LOC | 2 |
auckland | GPE | 2 |
aspirin atorvastatin | PERSON | 2 |
arabi yaseen | CHEMICAL | 2 |
après | PERSON | 2 |
appropriate | GPE | 2 |
antibiotic | LOC | 2 |
angiotensin | CHEMICAL | 2 |
alan isles | PERSON | 2 |
anaphylaxis | DISEASE | 2 |
analgo | ORG | 2 |
anakinra tocilizumab | PERSON | 2 |
anakinra kineret | PERSON | 2 |
amin pharmaceutical company | ORG | 2 |
american thoracic society | ORG | 2 |
american society of hematology ash | ORG | 2 |
albumin human | PERSON | 2 |
alanine | GPE | 2 |
clinicaltrial | ORG | 2 |
cov infection | DISEASE | 2 |
imm | CHEMICAL | 2 |
gum acacia | PERSON | 2 |
htn | ORG | 2 |
hta | ORG | 2 |
hrct | ORG | 2 |
hiv hepatitis b tuberculosis | DISEASE | 2 |
hit | DISEASE | 2 |
hiruz ctu | ORG | 2 |
hcg | CHEMICAL | 2 |
h5n1 | TAXON | 2 |
gum acacia improves renal function | CHEMICAL | 2 |
greece | GPE | 2 |
haemoptysis | GPE | 2 |
graphpad prism graphpad prism | ORG | 2 |
granollers | CHEMICAL | 2 |
grades | PERSON | 2 |
good clinical practice | ORG | 2 |
glucocorticoids | ORG | 2 |
gpower | ORG | 2 |
gold | ORG | 2 |
glm | ORG | 2 |
gdpr gcp | ORG | 2 |
haematuria | DISEASE | 2 |
haemoptysis hematemesis | DISEASE | 2 |
functional assessment of cancer therapy breast cancer fact b 26 | ORG | 2 |
hutchinson cancer | DISEASE | 2 |
imi | ORG | 2 |
idaci | ORG | 2 |
ibm corp armonk ny usa graphs | ORG | 2 |
hôpitaux universitaires de strasbourg | PERSON | 2 |
hôpital lariboisière | ORG | 2 |
hz | ORG | 2 |
hypoxemia | GPE | 2 |
hyposmia | ORG | 2 |
hypertensive | DISEASE | 2 |
hungary | GPE | 2 |
health care utilisation questionnaire | ORG | 2 |
huashan | GPE | 2 |
huarui sanjiu | PERSON | 2 |
householders | CHEMICAL | 2 |
hospital de granollers | ORG | 2 |
hospital clinic | ORG | 2 |
home streamlined | ORG | 2 |
home plus | ORG | 2 |
hochberg | PERSON | 2 |
helsinki | GPE | 2 |
gdpr | ORG | 2 |
fudan university | ORG | 2 |
covid | DISEASE | 2 |
d comparisons of group a | ORG | 2 |
daval | DISEASE | 2 |
data and safety monitoring board | ORG | 2 |
dans le groupe | PERSON | 2 |
drc | ORG | 2 |
dr | DISEASE | 2 |
dmid | ORG | 2 |
denv infections | DISEASE | 2 |
d14 d28 | PERSON | 2 |
d11 therapeutic | ORG | 2 |
critically ill | DISEASE | 2 |
deltamethrin | PERSON | 2 |
cough | DISEASE | 2 |
corticosteroids | PERSON | 2 |
corticosteroid | GPE | 2 |
coronavirus infections | DISEASE | 2 |
coronavirus infected pneumonia | DISEASE | 2 |
comprehensive | ORG | 2 |
comparing | GPE | 2 |
comparer | ORG | 2 |
comorbidity | ORG | 2 |
decuypere jana | PERSON | 2 |
des | CHEMICAL | 2 |
ferritin | GPE | 2 |
epidemiological | ORG | 2 |
femme enceinte | CHEMICAL | 2 |
full | ORG | 2 |
fsh | ORG | 2 |
frc | ORG | 2 |
fgh | ORG | 2 |
european stroke organisation eso | ORG | 2 |
ethics committee s and competent authority | ORG | 2 |
estrogen | ORG | 2 |
epistaxis | DISEASE | 2 |
envelopes | LOC | 2 |
developmental | ORG | 2 |
england northern ireland wales | ORG | 2 |
eso | CHEMICAL | 2 |
elisa | ORG | 2 |
e coli | TAXON | 2 |
dornase | ORG | 2 |
dolquine | CHEMICAL | 2 |
dietary | ORG | 2 |
diagnosis | GPE | 2 |
diabetes mellitus | PERSON | 2 |
still s disease | DISEASE | 2 |
sponsor this dsur | ORG | 2 |
strasbourg | GPE | 2 |
il leur sera | PERSON | 2 |
photophobia | GPE | 2 |
peripheral white blood cell count | DISEASE | 2 |
pathologies | DISEASE | 2 |
parasites fungi | TAXON | 2 |
oxygen desaturation | CHEMICAL | 2 |
oxacillin | CHEMICAL | 2 |
ovitraps | TAXON | 2 |
outbreaks | TAXON | 2 |
organ dysfunction | DISEASE | 2 |
olfactory loss | DISEASE | 2 |
oedema | DISEASE | 2 |
odorat sans obstruction | DISEASE | 2 |
odorat | CHEMICAL | 2 |
obstruction | DISEASE | 2 |
nous ne connaissons pas encore les conséquences | CHEMICAL | 2 |
noradrenaline | CHEMICAL | 2 |
nonemployees | CHEMICAL | 2 |
non academic internal medicine units 2 infectious disease units | ORG | 2 |
nitrite | CHEMICAL | 2 |
neutrophil chemotaxis | PERSON | 2 |
necrosis | DISEASE | 2 |
physical injury | DISEASE | 2 |
physiologique dès l | PERSON | 2 |
piperacillin tazobactam | CHEMICAL | 2 |
pulmonary infiltrates | DISEASE | 2 |
respiratory tract infections | DISEASE | 2 |
renal impairment | DISEASE | 2 |
rash | DISEASE | 2 |
rales heart murmurs peripheral edema | DISEASE | 2 |
rabbits | TAXON | 2 |
qui | ORG | 2 |
que les | PERSON | 2 |
qif1k62 | CHEMICAL | 2 |
pulmonary inflammation | DISEASE | 2 |
pulmonary embolism myocardial infarction myocarditis | DISEASE | 2 |
platelet aggregation | DISEASE | 2 |
pulmonary embolism | DISEASE | 2 |
pulmonary edema | DISEASE | 2 |
pulmonary dysfunction | DISEASE | 2 |
pulmonary alveolar proteinosis | DISEASE | 2 |
propionate | CHEMICAL | 2 |
procalcitonin | CHEMICAL | 2 |
premiers | CHEMICAL | 2 |
prematurity | DISEASE | 2 |
pneumonia infections | DISEASE | 2 |
nausea | DISEASE | 2 |
nasal septoplasty | PERSON | 2 |
nasal carriage | DISEASE | 2 |
intracerebral haemorrhage | DISEASE | 2 |
kidney injury | DISEASE | 2 |
kidney disease | DISEASE | 2 |
jour jusqu | PERSON | 2 |
itraconazole voriconazole posaconazole | CHEMICAL | 2 |
itraconazole ketoconazole clarithromycin | CHEMICAL | 2 |
itching rash | DISEASE | 2 |
investigateur notifie sans délai | CHEMICAL | 2 |
intérêts | CHEMICAL | 2 |
intraocular bleed | DISEASE | 2 |
injury illness infection | DISEASE | 2 |
lepirudin | PERSON | 2 |
informatique | CHEMICAL | 2 |
influenza virus pneumonia | DISEASE | 2 |
infectious disease | DISEASE | 2 |
infectious dermatitis | DISEASE | 2 |
infectious complications ventilator dependency | DISEASE | 2 |
infections sepsis | DISEASE | 2 |
incapacity | DISEASE | 2 |
impairment memory impairment fatigue pain dyspnea nausea vomiting insomnia anorexia diarrhea constipation | DISEASE | 2 |
impaired lung function | DISEASE | 2 |
le promoteur | CHEMICAL | 2 |
leukocyte | PERSON | 2 |
médiane | GPE | 2 |
microbiome | TAXON | 2 |
médecins | CHEMICAL | 2 |
myocardial injury | DISEASE | 2 |
myocardial inflammation | DISEASE | 2 |
multiple organ failure | DISEASE | 2 |
multicenter national observational cohorts study | ORG | 2 |
moins | CHEMICAL | 2 |
modèle de régression logistique ajusté sur | PERSON | 2 |
mm hg | PERSON | 2 |
mitoxantrone | CHEMICAL | 2 |
methylhistidine | CHEMICAL | 2 |
lipopolysaccharide | CHEMICAL | 2 |
mcg ml | PERSON | 2 |
matin | ORG | 2 |
malformation | DISEASE | 2 |
macrolide azithromycin | CHEMICAL | 2 |
lupus erythematosus | DISEASE | 2 |
lung injury vili | DISEASE | 2 |
lung infection | DISEASE | 2 |
lung diseases | DISEASE | 2 |
lopinavir ritonavir hydroxy chloroquine | CHEMICAL | 2 |
retroperitoneal bleeding | DISEASE | 2 |
rocuronium | CHEMICAL | 2 |
roxithromycin | CHEMICAL | 2 |
the world health organization | ORG | 2 |
twostage | CHEMICAL | 2 |
tumour necrosis | DISEASE | 2 |
tumor necrosis | DISEASE | 2 |
triglyceride | CHEMICAL | 2 |
transferrin | CHEMICAL | 2 |
tissue injury | DISEASE | 2 |
thrombotic microangiopathy | DISEASE | 2 |
thrombi | DISEASE | 2 |
thoracique | DISEASE | 2 |
the who working group | ORG | 2 |
uk | GPE | 2 |
the university of southampton | ORG | 2 |
the university hospital southampton nhs foundation trust | ORG | 2 |
the university hospital ghent | ORG | 2 |
the united kingdom | GPE | 2 |
the trial steering committee | ORG | 2 |
the study data | ORG | 2 |
the sponsor and principal investigators | ORG | 2 |
the resource utilization | ORG | 2 |
the research ethics committee | ORG | 2 |
u507i0t0 | CHEMICAL | 2 |
underdosing | DISEASE | 2 |
the quintet recruitment intervention | ORG | 2 |
virus adenovirus | TAXON | 2 |
stroke precious | PERSON | 2 |
évalue | CHEMICAL | 2 |
zilucoplan | GPE | 2 |
yeast | TAXON | 2 |
xylometazoline | CHEMICAL | 2 |
www medresman org | PERSON | 2 |
warfarin | CHEMICAL | 2 |
vitamin k | CHEMICAL | 2 |
viruses mycoplasma | TAXON | 2 |
viral respiratory tract infections | DISEASE | 2 |
unstable angina | DISEASE | 2 |
viral pneumonias | DISEASE | 2 |
viral like illness | DISEASE | 2 |
viral acute lung injury | DISEASE | 2 |
violent | DISEASE | 2 |
ventricular failure | DISEASE | 2 |
vascular aneurysms arteriovenous malformations | DISEASE | 2 |
varicella zoster | DISEASE | 2 |
urinary urea nitrogen | CHEMICAL | 2 |
urea creatinine | CHEMICAL | 2 |
the regional committee for medical and health research ethics | ORG | 2 |
the norwegian centre for research data | ORG | 2 |
s brochure | PERSON | 2 |
status epilepticus | DISEASE | 2 |
the china clinical trial registry | ORG | 2 |
telaprevir fibric acid | CHEMICAL | 2 |
tamponade | DISEASE | 2 |
tachypnoea | DISEASE | 2 |
syncope incontinence | DISEASE | 2 |
stroke peptic ulcer malignant cancer | DISEASE | 2 |
stroke infection | DISEASE | 2 |
streptozotocin | CHEMICAL | 2 |
stoppé mais | PERSON | 2 |
status asthmaticus | DISEASE | 2 |
the clinical characteristics of covid | ORG | 2 |
statin atorvastatin | PERSON | 2 |
soit un | ORG | 2 |
sleep apnea | DISEASE | 2 |
sickle cell anemia | DISEASE | 2 |
sheep | TAXON | 2 |
seroconversions | DISEASE | 2 |
sera | PERSON | 2 |
septoplasty versus medical | ORG | 2 |
septicaemia | DISEASE | 2 |
the chu tse wu foundation for science technology development | ORG | 2 |
the clinical study center | ORG | 2 |
the national institutional review board | ORG | 2 |
the health innovation and research institute | ORG | 2 |
the national institutes of health | ORG | 2 |
the methodological and statistical unit | ORG | 2 |
the medical monitor | ORG | 2 |
the low dose lmwh | ORG | 2 |
the kfsh rc | ORG | 2 |
the intensive care units icus | ORG | 2 |
the informed consent form | ORG | 2 |
the information security committee | ORG | 2 |
the indigenous reference group of the child health division | ORG | 2 |
the hiruz clinical trial unit | ORG | 2 |
the competent authority | ORG | 2 |
the general data protection regulation | ORG | 2 |
the french ministry of health phrci | ORG | 2 |
the eye and ent hospital of fudan university | ORG | 2 |
the european parliament | ORG | 2 |
the eortc quality of life group | ORG | 2 |
the data and safety monitoring board | ORG | 2 |
the data management department | ORG | 2 |
the danish lung medicine association | ORG | 2 |
the competent authority famhp | ORG | 2 |
immobility | DISEASE | 2 |
the asia pacific region | LOC | 2 |
il existe des données de la | PERSON | 2 |
affection | DISEASE | 2 |
anomalies | DISEASE | 2 |
anakinra anakinra | PERSON | 2 |
alprostadil | CHEMICAL | 2 |
allaitante | DISEASE | 2 |
aliquots | PERSON | 2 |
airway injury | DISEASE | 2 |
airway inflammatory disease | DISEASE | 2 |
airway infection | DISEASE | 2 |
air c pao2 | ORG | 2 |
adverse drug reactions | DISEASE | 2 |
antihistamine | CHEMICAL | 2 |
adenine | CHEMICAL | 2 |
acute pulmonary embolism pe | DISEASE | 2 |
acute heart failure respiratory insufficiency | DISEASE | 2 |
acute bleeding | DISEASE | 2 |
acute vte | DISEASE | 2 |
active bleeding | DISEASE | 2 |
acalabrutinib | ORG | 2 |
a national institutional review board cpp | ORG | 2 |
zurich | GPE | 2 |
anti inflammatory zilucoplan | PERSON | 2 |
arboviruses | TAXON | 2 |
zarin | GPE | 2 |
autoimmune pulmonary alveolar proteinosis | DISEASE | 2 |
birth defect | DISEASE | 2 |
bemcentinib first | ORG | 2 |
bacterium | TAXON | 2 |
bacterial super infections | DISEASE | 2 |
bacterial infection | DISEASE | 2 |
azithromycin syrup | CHEMICAL | 2 |
azithromycin azithromycin | CHEMICAL | 2 |
avian influenza | PERSON | 2 |
aux | ORG | 2 |
aureus bacteremia | DISEASE | 2 |
arrhythmia | DISEASE | 2 |
auditory and vestibular function | DISEASE | 2 |
atrial hypertension | DISEASE | 2 |
atrial fibrillation venous thromboembolism | DISEASE | 2 |
atorvastatin statin | PERSON | 2 |
atorvastatin pravastatin | PERSON | 2 |
atorvastatin statin | PERSON | 2 |
astenia headache | PERSON | 2 |
aspirin simvastatin | PERSON | 2 |
aspiration infections | DISEASE | 2 |
zhou et al | PERSON | 2 |
xa | PERSON | 2 |
blurred vision | DISEASE | 2 |
ttci | ORG | 2 |
thoracic society of australia | ORG | 2 |
the local ethics committee the co ordinating | ORG | 2 |
the world health organization | ORG | 2 |
the sponsor investigator | ORG | 2 |
the red cross | ORG | 2 |
table 1 | GPE | 2 |
taastrup denmark | PERSON | 2 |
ttp ehealth | ORG | 2 |
ttp | DISEASE | 2 |
trial registration clinicaltrials | ORG | 2 |
tni | ORG | 2 |
tf | ORG | 2 |
terena | ORG | 2 |
teae | ORG | 2 |
tcz | ORG | 2 |
tcm syndrome | DISEASE | 2 |
swabs | CHEMICAL | 2 |
hypotonia | DISEASE | 2 |
studies | ORG | 2 |
study alxn1210 cov 305 | ORG | 2 |
thrombotic | LOC | 2 |
tocilizumab tratamientos | PERSON | 2 |
x ray | PERSON | 2 |
vng | ORG | 2 |
written | PERSON | 2 |
windows graphpad software san diego ca | GPE | 2 |
west norway | GPE | 2 |
wales | GPE | 2 |
wtl | ORG | 2 |
vitamin a | ORG | 2 |
villar | GPE | 2 |
vertigo | PERSON | 2 |
vermeersch stéfanie | CHEMICAL | 2 |
united states | GPE | 2 |
townsville | PERSON | 2 |
uz ghent | ORG | 2 |
uz gent | ORG | 2 |
uk medical research council | ORG | 2 |
uf | ORG | 2 |
tübingen | CHEMICAL | 2 |
turkey | GPE | 2 |
treatments | ORG | 2 |
traumabase | ORG | 2 |
trans european research and education networking association | ORG | 2 |
blindness | DISEASE | 2 |
vestibular dysfunction | DISEASE | 2 |
bovine | TAXON | 2 |
des hyposmies | CHEMICAL | 2 |
début des symptômes | CHEMICAL | 2 |
début des signes d infection | CHEMICAL | 2 |
début des premiers symptômes d infection | CHEMICAL | 2 |
début | CHEMICAL | 2 |
dyspnea wheeze bronchospasm stridor | DISEASE | 2 |
dyspnea coughing malaise fever | DISEASE | 2 |
dying | DISEASE | 2 |
dt3li3bk | DISEASE | 2 |
drug s concomitant disease s | DISEASE | 2 |
drug inherited coagulation abnormalities | DISEASE | 2 |
domestic | TAXON | 2 |
dizziness handicap | DISEASE | 2 |
diseases | DISEASE | 2 |
discoloration | DISEASE | 2 |
disability | DISEASE | 2 |
digoxin | CHEMICAL | 2 |
diabetic | DISEASE | 2 |
diabetes mellitus | DISEASE | 2 |
dexmedetomidine ketamine | PERSON | 2 |
designee | PERSON | 2 |
des signes la société française d | CHEMICAL | 2 |
début des symptômes hyposmie persistante | CHEMICAL | 2 |
endothelitis | DISEASE | 2 |
entraîne | CHEMICAL | 2 |
gustatives | DISEASE | 2 |
human granulocyte | TAXON | 2 |
human coronavirus hku1 | TAXON | 2 |
bradycardia | DISEASE | 2 |
hypercoagulable | DISEASE | 2 |
honoraria | GPE | 2 |
homeostasis disturbance muscle wasting | DISEASE | 2 |
headache conjunctivitis arthralgia | PERSON | 2 |
hallucinations | DISEASE | 2 |
haematological cancer | DISEASE | 2 |
gravité de l | PERSON | 2 |
entre la présence | PERSON | 2 |
gingival bleeding | DISEASE | 2 |
gemfibrozil niacin azole | CHEMICAL | 2 |
gastrointestinal bleeding | DISEASE | 2 |
fungal infection | DISEASE | 2 |
fichiers | CHEMICAL | 2 |
fever cough shortness | DISEASE | 2 |
fatty acids | CHEMICAL | 2 |
fatigue pain | DISEASE | 2 |
external bony deformity | DISEASE | 2 |
des personnes qui ne | CHEMICAL | 2 |
envoyée | CHEMICAL | 2 |
des excipients | CHEMICAL | 2 |
cette recherche droit d accès | CHEMICAL | 2 |
clopidogrel | ORG | 2 |
clexane | CHEMICAL | 2 |
chronic rhinosinusitis | DISEASE | 2 |
chronic lung dysfunction | DISEASE | 2 |
chronic lung diseases copd asthma bronchiectasis interstitial lung disease | DISEASE | 2 |
chronic lung diseases | DISEASE | 2 |
chronic disease | DISEASE | 2 |
chikungunya | DISEASE | 2 |
cette visite la prise en charge des | CHEMICAL | 2 |
cette anomalie | CHEMICAL | 2 |
coauteurs | CHEMICAL | 2 |
centre les | PERSON | 2 |
catecholamine | CHEMICAL | 2 |
carbon dioxide uric acid | CHEMICAL | 2 |
cancer cachexia | DISEASE | 2 |
cancer a | DISEASE | 2 |
dernier | DISEASE | 2 |
c6pbr64i | DISEASE | 2 |
bronchospasm | DISEASE | 2 |
bronchitis | DISEASE | 2 |
coagulation inflammation | DISEASE | 2 |
cahier | CHEMICAL | 2 |
cognitive impairment | DISEASE | 2 |
coronavirus sars cov | DISEASE | 2 |
dengue fever | DISEASE | 2 |
complexity | DISEASE | 2 |
death bleeding | DISEASE | 2 |
de cette consultation sera | ORG | 2 |
dans le groupe | PERSON | 2 |
cyanosis crepitation s | DISEASE | 2 |
couvertes | CHEMICAL | 2 |
cough wheeze | DISEASE | 2 |
coronavirus pneumonia | DISEASE | 2 |
coronavirus infection | DISEASE | 2 |
depressive | DISEASE | 2 |
coptrin | CHEMICAL | 2 |
conjugated linoleic acid acetate | CHEMICAL | 2 |
constipation | DISEASE | 2 |
confirmant | CHEMICAL | 2 |
confusion | DISEASE | 2 |
concomitant drug s concomitant disease s the relationship | DISEASE | 2 |
conjunctival bleed | DISEASE | 2 |
constaté | CHEMICAL | 2 |
mahmoodpoor | ORG | 1 |
marwa maghrabi | CHEMICAL | 1 |
martin guilliams | PERSON | 1 |
marco | CHEMICAL | 1 |
marnik vuylsteke | PERSON | 1 |
markus waitz | PERSON | 1 |
markov | PERSON | 1 |
mary daval service | PERSON | 1 |
majid | PERSON | 1 |
mark d | PERSON | 1 |
marietta marco vandelli | ORG | 1 |
margaret ackerman dartmouth college serum | ORG | 1 |
marsh | PERSON | 1 |
mantel haenszel mh | PERSON | 1 |
marc guinovart | PERSON | 1 |
manuel irazola vilma | PERSON | 1 |
mansilla | TAXON | 1 |
manrique saide | CHEMICAL | 1 |
manrique | GPE | 1 |
mannose | PERSON | 1 |
mandourah yasser al mekhlafi | PERSON | 1 |
mathias candusso | PERSON | 1 |
manasco | GPE | 1 |
malik et al | PERSON | 1 |
male | ORG | 1 |
mala | CHEMICAL | 1 |
major thromboembolic events | ORG | 1 |
mashhad university of medical sciences mashhad | ORG | 1 |
medical director of respiratory innovation wales | ORG | 1 |
matthieu baril | PERSON | 1 |
meier km | PERSON | 1 |
methyl histidine | CHEMICAL | 1 |
magnitude | PERSON | 1 |
methyl | LOC | 1 |
meteran | CHEMICAL | 1 |
meta | ORG | 1 |
messages | ORG | 1 |
merida yucatan | PERSON | 1 |
merida simulating | PERSON | 1 |
menzies | GPE | 1 |
mendoza azael kirstein oscar | PERSON | 1 |
menarini | PERSON | 1 |
melbourne | GPE | 1 |
meier | GPE | 1 |
maurice paykel place east tamaki | ORG | 1 |
mehta 2020 | PERSON | 1 |
medicines and healthcare products regulatory agency | ORG | 1 |
medicine azienda | ORG | 1 |
medication review organization of activities | ORG | 1 |
medical patients | ORG | 1 |
medical ethics committee | ORG | 1 |
medcalc statistical software | ORG | 1 |
medcalc | ORG | 1 |
mechanical | ORG | 1 |
mcphail steven | PERSON | 1 |
mcmc | PERSON | 1 |
maximizing independence at | ORG | 1 |
mahendran | CHEMICAL | 1 |
map spo 2 fio 2 v | ORG | 1 |
maes bastiaan van damme karel | PERSON | 1 |
maes bastiaan bosteels | PERSON | 1 |
mers cov | ORG | 1 |
mers 1 | GPE | 1 |
menm | ORG | 1 |
mends | GPE | 1 |
medical | ORG | 1 |
mdl_2020_10 | CHEMICAL | 1 |
md hospital | ORG | 1 |
md | ORG | 1 |
mcs mental component summary pcs physical component summary pd | ORG | 1 |
mbs pbs | ORG | 1 |
mb | PERSON | 1 |
mar | ORG | 1 |
lymphoid leukemia | DISEASE | 1 |
lung | PERSON | 1 |
lucia roche | ORG | 1 |
lucia righini marc rosemann | PERSON | 1 |
lower | ORG | 1 |
low molecular | PERSON | 1 |
low | PERSON | 1 |
lovenox | ORG | 1 |
lot | PERSON | 1 |
lorsque la recherche est réalisée dans | PERSON | 1 |
lorcan | CHEMICAL | 1 |
longterm | PERSON | 1 |
longini natalie dean | PERSON | 1 |
methylprednisolone valacyclovir | CHEMICAL | 1 |
long term oxygen therapy | ORG | 1 |
mers cov mers | ORG | 1 |
mers cov variable | ORG | 1 |
mers cov infection | DISEASE | 1 |
mri | ORG | 1 |
mady | CHEMICAL | 1 |
madagascar madagascar | ORG | 1 |
macrophage | ORG | 1 |
macrolides | CHEMICAL | 1 |
mackay ian m morris | PERSON | 1 |
mac | PERSON | 1 |
mz | CHEMICAL | 1 |
myd88 | PERSON | 1 |
mvpa 1 min | PERSON | 1 |
mums | ORG | 1 |
ms as mn | ORG | 1 |
mri patient | ORG | 1 |
mrgn | ORG | 1 |
mers infection | DISEASE | 1 |
mrc dyspnoea | DISEASE | 1 |
mplus data | ORG | 1 |
mo | GPE | 1 |
mmse | ORG | 1 |
mm | PERSON | 1 |
mkr | ORG | 1 |
mir | ORG | 1 |
mip1α | DISEASE | 1 |
mhg | ORG | 1 |
mh e mh | CHEMICAL | 1 |
mf | PERSON | 1 |
methods using | ORG | 1 |
methylprednisolone 1mg kg | PERSON | 1 |
noac | ORG | 1 |
metro south health research | ORG | 1 |
mexico strengths | GPE | 1 |
nk | GPE | 1 |
niv respirator | ORG | 1 |
nimp | ORG | 1 |
nihr clrn | ORG | 1 |
nih niaid | ORG | 1 |
nih behavior change consortium | ORG | 1 |
nice ash 45 | ORG | 1 |
nhmrc gm | ORG | 1 |
netinduced | ORG | 1 |
nd | GPE | 1 |
nct04445935 | DISEASE | 1 |
nct04399317 | DISEASE | 1 |
nct04381871 | CHEMICAL | 1 |
nct04369469 | CHEMICAL | 1 |
nct04361474 | CHEMICAL | 1 |
nct04336254 | CHEMICAL | 1 |
nct04315298 | CHEMICAL | 1 |
nct04110340 registered | PERSON | 1 |
nct04110340 | CHEMICAL | 1 |
nct04066868 registered | ORG | 1 |
nct04043364 | CHEMICAL | 1 |
nct03368092 registered | PERSON | 1 |
nct03111212 registered | PERSON | 1 |
nct03111212 | CHEMICAL | 1 |
nct02845843 registered | ORG | 1 |
nct02845843 | CHEMICAL | 1 |
nct02595060 | CHEMICAL | 1 |
nks olaviken gerontopsychiatric hospital | ORG | 1 |
nl54304 | CHEMICAL | 1 |
nlr nlr | PERSON | 1 |
nasal polyposis | DISEASE | 1 |
london local government association | ORG | 1 |
national and hospital protocols declaration | ORG | 1 |
national institutes of health stroke scale bp | ORG | 1 |
national institutes of health stroke scale | ORG | 1 |
national institute on deafness and other communication disorders | ORG | 1 |
national institute of public health | ORG | 1 |
national inst of mental health prentice hall | ORG | 1 |
national | ORG | 1 |
natalie e | CHEMICAL | 1 |
nasopharyngeal | PERSON | 1 |
nasendoscopic | ORG | 1 |
nasal spray | PERSON | 1 |
nasal obstruction symptom evaluation scale nose | ORG | 1 |
nomid syndrome | DISEASE | 1 |
nasal airway obstruction study nairos | ORG | 1 |
nacl 0 9 250 | CHEMICAL | 1 |
nacl 0 9 2 5 | CHEMICAL | 1 |
nyha klasse iii | PERSON | 1 |
nyha | GPE | 1 |
nvivo | ORG | 1 |
nv1 | ORG | 1 |
numbers to | CHEMICAL | 1 |
nt indigenous | ORG | 1 |
nss | CHEMICAL | 1 |
nsaid | ORG | 1 |
ns 43 | ORG | 1 |
nct02261506 | CHEMICAL | 1 |
nct02056340 | CHEMICAL | 1 |
nairos authors | ORG | 1 |
minoarisoa | TAXON | 1 |
mohammed mady ahmed fowler | PERSON | 1 |
mohammad moeini | PERSON | 1 |
mohammad de vol edward hijazi mohammed | PERSON | 1 |
mohamed bajhmom wail hussein mohamed | PERSON | 1 |
moeller | CHEMICAL | 1 |
modena italy | DISEASE | 1 |
model of care intervention | ORG | 1 |
mobilization observation behavior intensity dementia pain scale mobid | ORG | 1 |
moca eq | PERSON | 1 |
moca | PERSON | 1 |
mixed models | ORG | 1 |
missing data | ORG | 1 |
minneapolis mn usa | GPE | 1 |
molokhia | CHEMICAL | 1 |
mini mental state | ORG | 1 |
mindfulness stress reduction course | ORG | 1 |
miles griffiths gareth ho ling pei | PERSON | 1 |
mild grade 1 | ORG | 1 |
mike bray alison | PERSON | 1 |
mike bray | CHEMICAL | 1 |
middleton wen xu kate roberts | PERSON | 1 |
middelheim | CHEMICAL | 1 |
microbiome | TAXON | 1 |
michael bohnhorst | PERSON | 1 |
mexico s national center of preventive programs | ORG | 1 |
mexico zika | GPE | 1 |
mohsen rezvani | PERSON | 1 |
mometasone nasal spray | PERSON | 1 |
na | ORG | 1 |
murphy | ORG | 1 |
n methyl d aspartate | CHEMICAL | 1 |
n o p q r | ORG | 1 |
møller ulla weinrich sverrild | CHEMICAL | 1 |
myopathy | DISEASE | 1 |
myeloid leukemia breast | PERSON | 1 |
myeloid | DISEASE | 1 |
mycoplasma chlamydia | ORG | 1 |
myasthenia gravis | DISEASE | 1 |
myasthenia | GPE | 1 |
muzhda sonne | CHEMICAL | 1 |
muscular | DISEASE | 1 |
muscedere john | PERSON | 1 |
multiple organ failure | DISEASE | 1 |
mometasone furoate | CHEMICAL | 1 |
multi | GPE | 1 |
mullerian agenesis | DISEASE | 1 |
ms nathalie portier french ministry of health girci est chu de | ORG | 1 |
mowaia | CHEMICAL | 1 |
moulton 44 | ORG | 1 |
morton | DISEASE | 1 |
mortazi hassan | PERSON | 1 |
mortazi | CHEMICAL | 1 |
mortality intervention mortality | ORG | 1 |
mortality | DISEASE | 1 |
moraxella catarrhalis | PERSON | 1 |
montreal | GPE | 1 |
london public health england associations | ORG | 1 |
inhalation of gm csf | ORG | 1 |
london department of health our | ORG | 1 |
jose jesna al harthy | PERSON | 1 |
jc cc dc pl mh | ORG | 1 |
jb clinical | ORG | 1 |
jama | ORG | 1 |
jak2 | CHEMICAL | 1 |
j90 | PERSON | 1 |
italy baseline characteristics | ORG | 1 |
israel | GPE | 1 |
iquitos multi | ORG | 1 |
inès vigan womas | PERSON | 1 |
investigator paper | ORG | 1 |
intestinal symptoms diarrhoea vomiting fever | DISEASE | 1 |
international society of hypertension low and middle income countries committee | ORG | 1 |
international committee of medical journal editors | ORG | 1 |
international business machines corp | ORG | 1 |
interferon | ORG | 1 |
interactions | ORG | 1 |
intention | ORG | 1 |
intensive care unit | ORG | 1 |
intensive care society clinical trials group incidence | ORG | 1 |
intensive care school of medicine and public health | ORG | 1 |
intensité l intensité des événements | CHEMICAL | 1 |
intensité l | ORG | 1 |
intensité | TAXON | 1 |
int forum allergy rhinol olfactory | ORG | 1 |
insuffizienz akute | ORG | 1 |
instructions | ORG | 1 |
institutional review boards irb | ORG | 1 |
jd rr | PERSON | 1 |
jl nk | ORG | 1 |
jor | ORG | 1 |
jens ulrik jensen | PERSON | 1 |
jon cuff katharine | PERSON | 1 |
jokhdar | CHEMICAL | 1 |
john hunter hospital new south wales | ORG | 1 |
john hunter | PERSON | 1 |
johanna dürmüller bol | PERSON | 1 |
joanne morrison | PERSON | 1 |
jo ann elicia west | PERSON | 1 |
jingcheng dong | PERSON | 1 |
jiangsu | GPE | 1 |
jiang 2018 | PERSON | 1 |
jensen sidse graff | PERSON | 1 |
jensen | PERSON | 1 |
jens d jensen | PERSON | 1 |
js | ORG | 1 |
jennifer ryan marissa carrington | PERSON | 1 |
jeffreys | PERSON | 1 |
jean de dieu | PERSON | 1 |
je qualifierais | PERSON | 1 |
je ne sens rien du tout je | CHEMICAL | 1 |
janda monika mckavanagh | ORG | 1 |
jana lai | PERSON | 1 |
james rousseau | PERSON | 1 |
james joanne | PERSON | 1 |
james d gordon anthony mcgarvey | PERSON | 1 |
jy | GPE | 1 |
jwby bushen yiqi | PERSON | 1 |
institutional review board independent ethics committee | ORG | 1 |
institut pasteur de madagascar centre | ORG | 1 |
innovations strasbourg france | ORG | 1 |
irm de contrôle sera | ORG | 1 |
ido amit weizmann institute | ORG | 1 |
idiopathic sudden sensorineural hearing loss issnhl | DISEASE | 1 |
idiopathic sudden sensorineural hearing loss | DISEASE | 1 |
identifier nct04326920 | GPE | 1 |
iv akute | ORG | 1 |
iu | GPE | 1 |
issn hl | ORG | 1 |
iso9001 | CHEMICAL | 1 |
iso iec 27001 toutes | ORG | 1 |
iso | CHEMICAL | 1 |
ish | ORG | 1 |
isglobal | ORG | 1 |
irb all | ORG | 1 |
il ne nous paraît donc pas raisonnable de traiter par corticoïdes même locaux des | CHEMICAL | 1 |
ir injury | DISEASE | 1 |
iqr current | ORG | 1 |
ipm a | CHEMICAL | 1 |
ios | ORG | 1 |
intubate recruit surfactant extubate | CHEMICAL | 1 |
involve | ORG | 1 |
intervention and | ORG | 1 |
ind for anakinra | ORG | 1 |
incap institutional review board irb | ORG | 1 |
improve | ORG | 1 |
imp patient 20 | ORG | 1 |
im | ORG | 1 |
il inclura | PERSON | 1 |
immune response | ORG | 1 |
innate | ORG | 1 |
infections | DISEASE | 1 |
inka | CHEMICAL | 1 |
injury | DISEASE | 1 |
injection | ORG | 1 |
initiation | ORG | 1 |
inhalative | ORG | 1 |
neck surg | PERSON | 1 |
ingleheim | CHEMICAL | 1 |
informed consent forms | ORG | 1 |
information | ORG | 1 |
inflammation | DISEASE | 1 |
infectious disease | DISEASE | 1 |
infectious diseases society of america guidelines | ORG | 1 |
infancy | PERSON | 1 |
immunomodulatory agent | ORG | 1 |
induced venous thromboembolic | PERSON | 1 |
indoor | ORG | 1 |
indigenous | LOC | 1 |
india | GPE | 1 |
indexes review | ORG | 1 |
independent data monitoring committee | ORG | 1 |
incorrect | GPE | 1 |
incompatibilities | CHEMICAL | 1 |
inclusion criteria 1 | ORG | 1 |
inadequate | ORG | 1 |
improving | ORG | 1 |
impossible | PERSON | 1 |
jorge mendez | PERSON | 1 |
josefin eklöf | PERSON | 1 |
logit | ORG | 1 |
joseph mcdonnell | PERSON | 1 |
lapperre therese | PERSON | 1 |
lan demets | PERSON | 1 |
lamis | GPE | 1 |
lambton heights | LOC | 1 |
lambermont | LOC | 1 |
lambden | PERSON | 1 |
laboratory standards institute | ORG | 1 |
laboratorios rubió | ORG | 1 |
la traçabilité des | CHEMICAL | 1 |
la fondation adolphe de rothschild | ORG | 1 |
lsmeans | ORG | 1 |
lr | ORG | 1 |
lps | ORG | 1 |
lmw jmg ms | ORG | 1 |
lmw | ORG | 1 |
lmvpa | PERSON | 1 |
lmic | ORG | 1 |
live home path | ORG | 1 |
lib the dignity centre | ORG | 1 |
lft | ORG | 1 |
lars | DISEASE | 1 |
lar | DISEASE | 1 |
l n 66 | ORG | 1 |
l investigateur pourra interrompre | CHEMICAL | 1 |
l autorité compétente | CHEMICAL | 1 |
kyowa kirin medtronic merck nestlé novartis pfizer roche | ORG | 1 |
kufstein kufstein | ORG | 1 |
lariboisière | PERSON | 1 |
larsen alexander hoffmann | PERSON | 1 |
laura drinnan | PERSON | 1 |
lifelab southampton | PERSON | 1 |
log | PERSON | 1 |
los | GPE | 1 |
lomv vfd hospital | ORG | 1 |
lomv | ORG | 1 |
lisa buckingham | PERSON | 1 |
lisa | PERSON | 1 |
lipolysis | DISEASE | 1 |
linos vandekerckhove | PERSON | 1 |
lingwen kong | GPE | 1 |
limited melbourne victoria | PERSON | 1 |
limited melbourne vic | PERSON | 1 |
lifelong | GPE | 1 |
lifelab contamination | PERSON | 1 |
laure peyro saint | GPE | 1 |
lien de causalité | PERSON | 1 |
ley | PERSON | 1 |
lewis keir | PERSON | 1 |
leucine | CHEMICAL | 1 |
les informations | ORG | 1 |
lenhart audrey | PERSON | 1 |
leitlinie invasive beatmung | ORG | 1 |
lehman | ORG | 1 |
leebmann | CHEMICAL | 1 |
lee mckinnell | PERSON | 1 |
le cahier | CHEMICAL | 1 |
laurence horby peter olliaro piero | PERSON | 1 |
kruskal wallis | ORG | 1 |
krokeide | CHEMICAL | 1 |
kristine | CHEMICAL | 1 |
kfsh rc adult sedation protocol | ORG | 1 |
karl treskatsch | PERSON | 1 |
kanthi kavikondala miranda hunt shelley acres | PERSON | 1 |
kansai medical university | ORG | 1 |
kamandi mostafa azimi sajad | PERSON | 1 |
kaddam | GPE | 1 |
ky 2019299 | CHEMICAL | 1 |
ky | ORG | 1 |
kpz rs | PERSON | 1 |
kp ic ag | ORG | 1 |
kp | CHEMICAL | 1 |
kh | ORG | 1 |
kfsh rc hospital formulary medication | ORG | 1 |
kfo | ORG | 1 |
kartagener | GPE | 1 |
kek | ORG | 1 |
kce kce | ORG | 1 |
k potassium | ORG | 1 |
k 2 | ORG | 1 |
justus liebig university | ORG | 1 |
justification of the design unblinding procedures code | ORG | 1 |
junjun huang | PERSON | 1 |
junjun hu yan guo | PERSON | 1 |
julius valentin leebmann | PERSON | 1 |
julien noll | PERSON | 1 |
julie gottlieb vibeke meteran | PERSON | 1 |
joseph raseta befelatanana | PERSON | 1 |
karnofsky | PERSON | 1 |
kartagener s syndrome | DISEASE | 1 |
kristiansand innovation innovation | ORG | 1 |
kineret | PERSON | 1 |
kristiansand bergen | PERSON | 1 |
kristian Østergaard nielsen | PERSON | 1 |
kris tsenova | PERSON | 1 |
kong qing mo | PERSON | 1 |
kong lingwen lv yubao dong jingcheng | PERSON | 1 |
kolmogorov smirnov | PERSON | 1 |
knut shaw geoffrey | PERSON | 1 |
kjerstad egil | CHEMICAL | 1 |
kjell erik | CHEMICAL | 1 |
kirsten feist | PERSON | 1 |
king faisal specialist hospital | ORG | 1 |
king abdullah international medical research center | ORG | 1 |
kindgen | CHEMICAL | 1 |
katharine | CHEMICAL | 1 |
kim kyeong | PERSON | 1 |
kidney | ORG | 1 |
khartoum sudan placebo | ORG | 1 |
kharma nadir | PERSON | 1 |
keywords nasal | PERSON | 1 |
keywords endoscopic | ORG | 1 |
keywords bacteremia bloodstream | ORG | 1 |
key inclusion | ORG | 1 |
kennis centrum kce | ORG | 1 |
kelly michael duncan graeme | PERSON | 1 |
keith robertson colin f wilson | PERSON | 1 |
ke wu bin wu chu tse | PERSON | 1 |
nazionale | PERSON | 1 |
pyrethroid | ORG | 1 |
neck surgery chinese medical association | ORG | 1 |
sae trial management group a trial management group | ORG | 1 |
soc safety | ORG | 1 |
sle | DISEASE | 1 |
skp famhp | CHEMICAL | 1 |
shsc | ORG | 1 |
sf 12 physical component summary pcs | ORG | 1 |
sf 12 | ORG | 1 |
sefas | ORG | 1 |
sedcom nonpharmacologic | ORG | 1 |
scfas muscle loss | CHEMICAL | 1 |
scfas muscle | ORG | 1 |
sc jo h | ORG | 1 |
sbs | DISEASE | 1 |
sbrc | CHEMICAL | 1 |
sas institute cary nc usa | ORG | 1 |
sas institute cary nc a | ORG | 1 |
sartre study eudract number | ORG | 1 |
sartre study eudract | ORG | 1 |
sars coronavirus infection | DISEASE | 1 |
sars cov ma15 | ORG | 1 |
sars cov 2 infection | DISEASE | 1 |
sars cov 2 infection a | DISEASE | 1 |
sars cov 2 igm | ORG | 1 |
sars cov 19 | ORG | 1 |
sars cov 1 | ORG | 1 |
sar sae | ORG | 1 |
sap statistical | ORG | 1 |
sanofi | ORG | 1 |
sop | ORG | 1 |
sp | CHEMICAL | 1 |
spice iii ketamine | PERSON | 1 |
safety outcomes safety | ORG | 1 |
sarilumab | PERSON | 1 |
sargramostim leukine | PERSON | 1 |
sarah vogel christina lawrence | PERSON | 1 |
sarah jenner | PERSON | 1 |
sanofi regeneron clinicaltrials | ORG | 1 |
sandkötter julia | DISEASE | 1 |
sanaie | CHEMICAL | 1 |
sample | PERSON | 1 |
saline nasal spray sterimar | PERSON | 1 |
salam alex gillesen | PERSON | 1 |
sajad ataei | CHEMICAL | 1 |
saher burhan | PERSON | 1 |
safety set ss | ORG | 1 |
ss | ORG | 1 |
safety monitoring committee | ORG | 1 |
safety 22 | ORG | 1 |
safarian | CHEMICAL | 1 |
saeed eslami noferesti | ORG | 1 |
synapsys | GPE | 1 |
swi | ORG | 1 |
sw | ORG | 1 |
susar | ORG | 1 |
support | ORG | 1 |
ssy uady and emory university acute | ORG | 1 |
ssy emory university | ORG | 1 |
ssl | ORG | 1 |
safe | ORG | 1 |
sae medical | ORG | 1 |
need | ORG | 1 |
sab | CHEMICAL | 1 |
rhabdomyolysis cpk | ORG | 1 |
rhabdomyolysis | DISEASE | 1 |
reziky bourner | PERSON | 1 |
reversibility | ORG | 1 |
retinopathy maculopathy visual | PERSON | 1 |
resuscitation variation | LOC | 1 |
responsible research and innovation rri | ORG | 1 |
respiratory syncytial virus infection | DISEASE | 1 |
respiratory symptoms cough tachypnea haemotysis | DISEASE | 1 |
respiratory failure | DISEASE | 1 |
respiratory distress | DISEASE | 1 |
respiratory syndrome coronavirus 2 sars cov | DISEASE | 1 |
respiratory syndrome | DISEASE | 1 |
resource | ORG | 1 |
research electronic data capture vanderbilt university | ORG | 1 |
research council | ORG | 1 |
research | ORG | 1 |
reported outcome | PERSON | 1 |
reperfusion | DISEASE | 1 |
rennie katherine | PERSON | 1 |
renal disease | DISEASE | 1 |
remdesivir | PERSON | 1 |
reinhard kadam | PERSON | 1 |
regeneron | ORG | 1 |
references annexes ethics | ORG | 1 |
ref type | PERSON | 1 |
redox | ORG | 1 |
rheumatoid arthritis | DISEASE | 1 |
rheumatoid arthritis | DISEASE | 1 |
rhinol budesonide | CHEMICAL | 1 |
roehrig stefan shible ahmed atef | PERSON | 1 |
saa il | LOC | 1 |
rubió | DISEASE | 1 |
rubin 16 | PERSON | 1 |
royal adelaide hospital south australia | ORG | 1 |
royal adelaide hospital | ORG | 1 |
route | PERSON | 1 |
rota | GPE | 1 |
ross horsfall tina kalita | PERSON | 1 |
rosie mackay | PERSON | 1 |
ros horlock | PERSON | 1 |
romer yamila correa | PERSON | 1 |
roland colucci | PERSON | 1 |
roehrig stefan ait | PERSON | 1 |
rhinovirus | TAXON | 1 |
robert ware | PERSON | 1 |
robert downing | PERSON | 1 |
robert a | PERSON | 1 |
rizani ravindran | PERSON | 1 |
riyadh kingdom of saudi arabia | GPE | 1 |
riyadh | TAXON | 1 |
richmond agitation sedation score rass | ORG | 1 |
richmond | GPE | 1 |
richard reithinger | PERSON | 1 |
richard mcguinness | PERSON | 1 |
richard fowler | PERSON | 1 |
ribavirin | CHEMICAL | 1 |
sascha zemlin | PERSON | 1 |
sato | PERSON | 1 |
satti shahinaz | CHEMICAL | 1 |
saudi critical care trials group ribavirin | ORG | 1 |
stata spss | ORG | 1 |
stata planned | ORG | 1 |
staphylococcus aureus staphylococcus lugdunensis | DISEASE | 1 |
staphylococcus | LOC | 1 |
standardized | ORG | 1 |
standard of care for the early | ORG | 1 |
standard of care | ORG | 1 |
standard protocol item recommendations for interventional trials spirit | ORG | 1 |
standard error of mean sem | ORG | 1 |
stakeholder | PERSON | 1 |
st thomas publisher | ORG | 1 |
st joseph s | PERSON | 1 |
spraying | PERSON | 1 |
sponsor or a site | ORG | 1 |
sponsor | ORG | 1 |
specific | PERSON | 1 |
specialist nurse | ORG | 1 |
specialist cancer nurses | ORG | 1 |
spo 2 | ORG | 1 |
southampton university of southampton london ministry of housing communities local government | ORG | 1 |
southampton general hospital university | ORG | 1 |
southampton general hospital | ORG | 1 |
southampton data | ORG | 1 |
south america | LOC | 1 |
source vincent 1998 | PERSON | 1 |
soundio as | ORG | 1 |
sololá n 10 | ORG | 1 |
statement phenotypes | PERSON | 1 |
statens serum institute | ORG | 1 |
statens serum institute denmark | ORG | 1 |
stockpile leukine | PERSON | 1 |
il1 | PERSON | 1 |
study | PERSON | 1 |
strömmer sofia barrett millie woods townsend kathryn baird janis farrell david lord joanne | DISEASE | 1 |
strömmer sofia barrett | PERSON | 1 |
structured | ORG | 1 |
stroke rationale | PERSON | 1 |
strengths | DISEASE | 1 |
streiner | PERSON | 1 |
strasbourg university hospital significant | ORG | 1 |
strasbourg cedex service de physiologie et d explorations fonctionnelles disability | ORG | 1 |
stortecky stefan | PERSON | 1 |
storage | PERSON | 1 |
stockmann helena keller theresa | PERSON | 1 |
states enoxaparin | GPE | 1 |
stocken | CHEMICAL | 1 |
steven rogers | PERSON | 1 |
sterimar spray residuum | PERSON | 1 |
sterimar | GPE | 1 |
sterile | PERSON | 1 |
stepwise | ORG | 1 |
stephan kucher nils | PERSON | 1 |
stegomyia aegypti aedes aegypti | TAXON | 1 |
stefanie martus | PERSON | 1 |
steering committee | ORG | 1 |
statistical package for social sciences | ORG | 1 |
statistical analysis plan sap | ORG | 1 |
soler helena | PERSON | 1 |
sola md phd medical staff | ORG | 1 |
société hospitalière d assurances mutuelles | ORG | 1 |
screen germany | PERSON | 1 |
shaban | CHEMICAL | 1 |
serum | GPE | 1 |
sera data analysis | ORG | 1 |
septoplasty turbinates mometasone | ORG | 1 |
seifi najmeh | ORG | 1 |
section of respiratory medicine department of medicine gentofte hospital university | ORG | 1 |
section 9 statistical considerations | ORG | 1 |
secretarias | CHEMICAL | 1 |
second national institute of allergy and infectious disease food allergy and | ORG | 1 |
screening severe | ORG | 1 |
screening imaging | ORG | 1 |
screening | PERSON | 1 |
scott ritchie | PERSON | 1 |
shamsah | CHEMICAL | 1 |
scotland intervention | ORG | 1 |
scotland intervention | ORG | 1 |
scotland | GPE | 1 |
science coincidental | PERSON | 1 |
schools | PERSON | 1 |
school of public health boston university | ORG | 1 |
schoenhals | TAXON | 1 |
savarino | LOC | 1 |
sauleau erik | PERSON | 1 |
saudi food and drug authority fda | ORG | 1 |
saudi food and drug authority | ORG | 1 |
saudi fda clinicaltrials | ORG | 1 |
shaker | CHEMICAL | 1 |
shamsah rottinghaus scott | PERSON | 1 |
society of otorhinolaryngology head | ORG | 1 |
sipmann | CHEMICAL | 1 |
society of hematology 2018 | ORG | 1 |
society of critical care medicine | ORG | 1 |
society of anesthesiologists | ORG | 1 |
social | ORG | 1 |
soba university | ORG | 1 |
snoring tiredness | DISEASE | 1 |
smith keisha pace | ORG | 1 |
small | ORG | 1 |
slagelse | PERSON | 1 |
skeide | CHEMICAL | 1 |
sivapalan | GPE | 1 |
sites | ORG | 1 |
single | ORG | 1 |
shamsi mohsen bary | PERSON | 1 |
singapore | GPE | 1 |
simao | CHEMICAL | 1 |
signs | PERSON | 1 |
shurtleff et al | PERSON | 1 |
shurtleff | CHEMICAL | 1 |
shuming mo | LOC | 1 |
short form health survey sf 36 | ORG | 1 |
shi | PERSON | 1 |
shenzhen | GPE | 1 |
sheng di | PERSON | 1 |
shelf | ORG | 1 |
shanghai municipality grant number | ORG | 1 |
redcap | ORG | 1 |
reconstituted leukine | ORG | 1 |
reasonable | ORG | 1 |
pharmacology department | ORG | 1 |
pa02 | CHEMICAL | 1 |
pvs injuries | DISEASE | 1 |
pvc | ORG | 1 |
pv | ORG | 1 |
pur | ORG | 1 |
psn | ORG | 1 |
prrs | CHEMICAL | 1 |
pro data control group | ORG | 1 |
pp | CHEMICAL | 1 |
portier | CHEMICAL | 1 |
po pe | GPE | 1 |
po ag te | CHEMICAL | 1 |
po ag | ORG | 1 |
po | ORG | 1 |
pma 36 weeks | ORG | 1 |
pma | ORG | 1 |
pk pd immunogenicity change | ORG | 1 |
pk | ORG | 1 |
pic1 | PERSON | 1 |
pi3kgamma | CHEMICAL | 1 |
ph ads tf | CHEMICAL | 1 |
ph | CHEMICAL | 1 |
peep patients | PERSON | 1 |
peep hypoxaemia | PERSON | 1 |
pe bleeding | CHEMICAL | 1 |
pd evaluations | ORG | 1 |
pathos efficacy | ORG | 1 |
pao2 | GPE | 1 |
pao2 fio2 p f ratio | ORG | 1 |
package | ORG | 1 |
paul gaffarel bp | PERSON | 1 |
pfizer tf | ORG | 1 |
pfizer manufacturing belgium nv | ORG | 1 |
peter franz | PERSON | 1 |
peter | PERSON | 1 |
peru | GPE | 1 |
peralta | DISEASE | 1 |
peking university first hospital advertising | ORG | 1 |
pearson | ORG | 1 |
paula twynham | PERSON | 1 |
paul j bailey emily j mccallum gabrielle | PERSON | 1 |
paul hanson mark godfrey keith | PERSON | 1 |
paul haertel | PERSON | 1 |
paul docherty | PERSON | 1 |
paeoniae rubra radix | CHEMICAL | 1 |
patsy | CHEMICAL | 1 |
patienten mit einer akuten erkrankung wie herzinsuffizienz | CHEMICAL | 1 |
passive | ORG | 1 |
parlamento | ORG | 1 |
paracetamol acute | ORG | 1 |
paracetamol acetaminophen | CHEMICAL | 1 |
paniagua avila | PERSON | 1 |
pandharipande | GPE | 1 |
panama peru | GPE | 1 |